Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

George R Stark

Showing results (71-80 of 125) with videos related to

Pageof 13
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|August 2, 2013
PRMT5 dimethylates R30 of the p65 subunit to activate NF-κBHan Wei, Benlian Wang, Masaru Miyagi, et al.
Oncogene|April 6, 2004
Limited role of N-terminal phosphoserine residues in the activation of transcription by p53Mark W Jackson, Mukesh K Agarwal, Munna L Agarwal, et al.
Journal of Cell Science|April 14, 2005
p130/p107/p105Rb-dependent transcriptional repression during DNA-damage-induced cell-cycle exit at G2Mark W Jackson, Mukesh K Agarwal, Jinbo Yang, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|July 15, 2003
IRAK-dependent phosphorylation of Stat1 on serine 727 in response to interleukin-1 and effects on gene expressionHannah Nguyen, Moitreyee Chatterjee-Kishore, Zhengfan Jiang, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|June 13, 2002
Resistance to interferons in melanoma cells does not correlate with the expression or activation of signal transducer and activator of transcription 1 (Stat1)Mamta Chawla-Sarkar, Douglas W Leaman, Barbara S Jacobs, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 23, 2011
The role of cell type-specific responses in IFN-β therapy of multiple sclerosisJoana A Zula, Holly C Green, Richard M Ransohoff, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 10, 2004
Identification of a human NF-kappaB-activating protein, TAB3Ge Jin, Alison Klika, Michelle Callahan, et al.
Frontiers in Oncology|January 21, 2026
The CDK inhibitor Roscovitine enhances the therapeutic efficacy of anti-PD-1 in non-small cell lung cancerC Marcela Diaz-Montero, Elise G Holvey-Bates, Patricia A Rayman, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 7, 2009
Validation-based insertional mutagenesis identifies lysine demethylase FBXL11 as a negative regulator of NFkappaBTao Lu, Mark W Jackson, Aatur D Singhi, et al.
Nature Cancer|February 5, 2022
Pharmacological inhibition of BACE1 suppresses glioblastoma growth by stimulating macrophage phagocytosis of tumor cellsKui Zhai, Zhi Huang, Qian Huang, et al.
Pageof 13

Showing results (71-80 of 125) with videos related to

Sort By:
Pageof 13
Proceedings of the National Academy of Sciences of the United States of America|August 2, 2013
PRMT5 dimethylates R30 of the p65 subunit to activate NF-κBHan Wei, Benlian Wang, Masaru Miyagi, et al.
Oncogene|April 6, 2004
Limited role of N-terminal phosphoserine residues in the activation of transcription by p53Mark W Jackson, Mukesh K Agarwal, Munna L Agarwal, et al.
Journal of Cell Science|April 14, 2005
p130/p107/p105Rb-dependent transcriptional repression during DNA-damage-induced cell-cycle exit at G2Mark W Jackson, Mukesh K Agarwal, Jinbo Yang, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|July 15, 2003
IRAK-dependent phosphorylation of Stat1 on serine 727 in response to interleukin-1 and effects on gene expressionHannah Nguyen, Moitreyee Chatterjee-Kishore, Zhengfan Jiang, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|June 13, 2002
Resistance to interferons in melanoma cells does not correlate with the expression or activation of signal transducer and activator of transcription 1 (Stat1)Mamta Chawla-Sarkar, Douglas W Leaman, Barbara S Jacobs, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 23, 2011
The role of cell type-specific responses in IFN-β therapy of multiple sclerosisJoana A Zula, Holly C Green, Richard M Ransohoff, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 10, 2004
Identification of a human NF-kappaB-activating protein, TAB3Ge Jin, Alison Klika, Michelle Callahan, et al.
Frontiers in Oncology|January 21, 2026
The CDK inhibitor Roscovitine enhances the therapeutic efficacy of anti-PD-1 in non-small cell lung cancerC Marcela Diaz-Montero, Elise G Holvey-Bates, Patricia A Rayman, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 7, 2009
Validation-based insertional mutagenesis identifies lysine demethylase FBXL11 as a negative regulator of NFkappaBTao Lu, Mark W Jackson, Aatur D Singhi, et al.
Nature Cancer|February 5, 2022
Pharmacological inhibition of BACE1 suppresses glioblastoma growth by stimulating macrophage phagocytosis of tumor cellsKui Zhai, Zhi Huang, Qian Huang, et al.
Pageof 13